Azria
Research Subjects
Research Interests
Azria has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Benoît Pilmis
Institut Micalis UMR 1319, Université Paris-Saclay, INRAe, AgroParisTech , Orsay
1 shared publication - Borie
Department of Internal Medicine
1 shared publication - Deluca
Department of Internal Medicine
1 shared publication - Fite
Department of Dermatology
1 shared publication - Jean-Jacques Mourad
Comité français de lutte contre l'hypertension artérielle (CFLHTA), 5, rue des Colonnes-du-Trône, 75012 Paris, France; Unité médecine interne-HTA, hôpital Avicenne, 125, rue de Stalingrad, 93009 Bobigny, France
1 shared publication - Lelorc'H
Department of Internal Medicine
1 shared publication
Latest Publications
- Open Access
- 6 November 2020
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 29 (2) , e109-e110
Disseminated Herpes Zoster During COVID-19
During the SARS-CoV-2 pandemic, a variety of dermatological conditions were reported by physicians. Given the context, these lesions have been labeled as secondary to SARS-CoV-2 infection. We report the case of a recurrence of herpes zoster in a patient hospitalized with an SARS-CoV-2 infection. The rash occurred on the 15th day of hospitalization while the patient was recovering from a severe form. Local swab showed the presence of varicella-zoster virus within the vesicles. Dermatological symptoms secondary to COVID-19 have been frequently described. This is the first case that demonstrates the recurrence of herpes zoster during a SARS-CoV-2 infection.
- 6 November 2020
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 29 (2) , e109-e110
Open AccessDisseminated Herpes Zoster During COVID-19
During the SARS-CoV-2 pandemic, a variety of dermatological conditions were reported by physicians. Given the context, these lesions have been labeled as secondary to SARS-CoV-2 infection. We report the case of a recurrence of herpes zoster in a patient hospitalized with an SARS-CoV-2 infection. The rash occurred on the 15th day of hospitalization while the patient was recovering from a severe form. Local swab showed the presence of varicella-zoster virus within the vesicles. Dermatological symptoms secondary to COVID-19 have been frequently described. This is the first case that demonstrates the recurrence of herpes zoster during a SARS-CoV-2 infection.